Cargando…
A “vicious cycle” of NK-cell immune evasion in acute myeloid leukemia mediated by RANKL?
Receptor activator of NFκB ligand (RANKL) is mainly known for its role in bone metabolism, constituting a target for therapeutic interventions. Increasing evidence suggests that RANKL is also involved in oncogenesis and tumor progression, including a prominent role in host-tumor interaction. Our dat...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Landes Bioscience
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667891/ https://www.ncbi.nlm.nih.gov/pubmed/23762785 http://dx.doi.org/10.4161/onci.23850 |